research Post-Surgical Hair Loss in the Donor Site After Hair Transplantation: Anagen or Telogen Effluvium?
Hair loss at the site where hair was taken for a transplant can be due to the normal hair growth cycle.
Search
for
Sort by
Research
750-780 / 1000+ results research A Case Control Study to Determine the Correlation Between Serum Ferritin Levels and Chronic Telogen Effluvium in a Tertiary Hospital, Mandya
High ferritin levels might be linked to chronic hair loss.
research Mechanisms of Action and Medical Evidence of the Therapeutic Effect of Oral Gelatin on Telogen Effluvium and Androgenetic Alopecia in Both Men and Women
research Alteration in Asbabe-Sitta-Zaruriyah (Six Essential Prerequisites for Maintaining Health) to Prevent Intithar al-Sha‘r (Telogen Effluvium): An Insight
Changing six essential health practices can help prevent excessive hair shedding.
research Six-Month Prospective Study on the Effects of a Topical Product in Lotion and Shampoo Form Based on Low Molecular Weight Synthetic Thymus Peptides in Chronic Telogen Effluvium and Early Female Androgenetic Alopecia
research Principles of Hair Cycle Control
Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.
research Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.
research Follicular Swiss Cheese Pattern: Another Histopathologic Clue to Alopecia Areata
Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.
research A Hospital-Based Study to Determine Causes of Diffuse Hair Loss in Women
The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.
research Vitamin D Status in Scarring and Nonscarring Alopecia
People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.
research Causes of Diffuse Alopecia in Women
Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.
research Results of Low-Level Laser Therapy in the Treatment of Hair Growth: An Egyptian Experience
Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.
research Treatment of Pattern Baldness with Fiber Implantation
The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.
research Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss
Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.
research Nonscarring Scalp Alopecia: Which Laboratory Analysis Should We Perform on Whom?
Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.
research Responsiveness of the DLQI and the Colombian Validated Version of the Skindex-29 in Scarring and Non-Scarring Alopecia
Telogen effluvium most affects quality of life in alopecia patients.
research Comparison of Novel Hematological Biomarkers in Alopecia Areata and Other Non-Cicatricial Alopecia: A Retrospective Study
Blood cell counts could help predict and treat alopecia areata and telogen effluvium.
research A Study of the Clinical Patterns of Hair Loss in Female Patients
Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
research Telogen Effluvium: A Post-COVID-19 Sequela
COVID-19 may cause a common type of hair loss called telogen effluvium.
research Use of Vitamins and Minerals in Telogen Effluvium: A Review
Vitamins and minerals don't significantly affect hair loss treatment in patients with telogen effluvium.
research Prevalence of Non-Scarring Alopecia Among Female Patients Complaining of Hirsutism
Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.
research Correlation Between COVID-19 and Telogen Effluvium and Its Social Impacts
COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.
research Capillary Diseases in Patients Who Had COVID-19
COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.
research Infrared and High Frequency Ultrasound Imaging of Skin Lesions in Atopic Dermatitis and Psoriasis Vulgaris
Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.
research 184 Withdrawn
Sandalore® reduces hair shedding and increases hair volume in women with telogen effluvium.
research Hair Loss in Children: A Detailed Overview of Pediatric Alopecia
The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.
research Clinical and Trichoscopic Patterns of Hair Loss in Systemic Lupus Erythematosus and Its Correlation with Systemic Lupus Erythematosus Disease Activity Index
Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.
research Common Patterns and Etiologic Factors of Hair Loss for Women in Karak Governorate, Jordan
Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.
research Rehabilitating the Journal Club: A Review of Journal Clubs in Physical Medicine and Rehabilitation
The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.
research Influence of Nutritional Supplementation on the Treatment of Telogen Effluvium: Clinical and Digital Phototrichogram Evaluation in 60 Patients
Nutritional supplements can significantly reduce hair loss in telogen effluvium after three months.